SS
PROF

SBI Securities’s Profound Medical PROF Stock Holding History

SBI Securities’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$5 – 4176
2025
Q3 		$5 Buy
+1
New +$5 ﹤0.01% 4106

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

SBI Securities's PROF Position: Q4 2025 in Review

SBI Securities sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

SBI Securities first reported a position in PROF in Q3 2025 and held it in 1 quarter. The position peaked at $5 in Q3 2025. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • SBI Securities reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 1 Profound Medical share in Q4 2025, an estimated $5.
  • SBI Securities first reported a position in Profound Medical in Q3 2025 and held it in 1 quarter.
  • SBI Securities's Profound Medical position peaked at $5 in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.